Micronucleus induction and FISH analysis in buccal cells and lymphocytes of nurses administering antineoplastic drugs

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 628, Issue 1, 2007, Pages 11-18

  Cavallo, Delia ^a   Ursini, Cinzia Lucia ^a   Omodeo Salè, Emanuela ^b   Iavicoli, Sergio ^a  

^a ISPESL   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Antineoplastic drugs; Genotoxic effect; Micronucleus FISH assay; Nurses; Occupational exposure

Indexed keywords

ALKYLATING AGENT; ANEUGEN; ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; IFOSFAMIDE; METHOTREXATE; NAVELBINE; PACLITAXEL; TRABECTEDIN; VINCRISTINE;

ADULT; ARTICLE; CENTROMERE; CHEEK; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENOTOXICITY; GIEMSA STAIN; HUMAN; HUMAN CELL; LYMPHOCYTE; MALE; MICRONUCLEUS TEST; NURSE; OCCUPATIONAL EXPOSURE; OCCUPATIONAL TOXICOLOGY; PRIORITY JOURNAL; WARD;

ADULT; ANTINEOPLASTIC AGENTS; DRUG COMBINATIONS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOCYTES; MALE; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MICRONUCLEUS TESTS; MOUTH MUCOSA; NURSES; OCCUPATIONAL EXPOSURE;

EID: 33847172197     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2006.10.014     Document Type: Article

References (40)

1. Boos G., and Stopper H. Genotoxicity of several clinically used topoisomerase II inhibitors. Toxicol. Lett. 116 (2000) 7-16
2. Digue L., Orsiere T., Baciuchka-Palmaro M., Duffaud F., Pompili J., Favre R., and Botta A. Interest of studying the in vitro genotoxicity of an antineoplastic drug on health human cells: example. Bull. Cancer 89 10 (2002) 887-892
3. Aydemir N., and Bilaloglu R. Genotoxicity of two anticancer drugs, gemcitabine and topotecan, in mouse bone marrow in vivo. Mutat. Res. 537 1 (2003) 43-51
4. Dhawan A., Kayani M.A., Parry J.M., Parry E., and Anderson D. Aneugenic and clastogenic effects of doxorubicin in human lymphocytes. Mutagenesis 18 6 (2003) 487-490
5. Lahdetie J., Keiski A., Suutari A., and Toppari J. Etoposide (VP-16) is a potent inducer of micronuclei in male rat meiosis: spermatid micronucleus test and DNA flow cytometry after etoposide treatment. Environ. Mol. Mutagen. 24 3 (1994) 192-202
6. Choudhury R.C., Das B., Misra S., and Jagdale M.B. Cytogenetic toxicity of vincristine. J. Environ. Pathol. Toxicol. Oncol. 19 4 (2000) 347-355
7. Turner S.D., Wijnhoven S.W.P., Tinwell H., Lashford L.S., Rafferty J.A., Ashby J., Vrieling H., and Fairbairn L.J. Assay to predict the genotoxicity of the chromosomal mutagen etoposide-focussing on the best assay. Mutat. Res. 493 (2001) 139-147
8. Zuniga-Gonzales G.M., Torres-Bugarin O., Zamora-Perez A.L., Gomez-Meda B.C., Ramos-Ibarra M.L., Gallegos-Arreola P., Flores-Garcia A., and Lopez-Uribe A. Induction of micronucleated erythocytes in mouse peripheral blood after cutaneous application of 5-fluorouracil. Arch. Med. Res. 34 2 (2003) 141-144
9. Choudhury R.C., Palo A.K., and Padhy A. Cytogenetic consequences of vinblastine treatment in mouse bone marrow. Chemoterapy 50 4 (2004) 171-177
10. Choudhury R.C., Palo A.K., and Sahu P. Cytogenetic risk assessment of etoposide from mouse bone marrow. J. Appl Toxicol. 24 (2004) 115-122
11. Acar H., Caliskan U., Demirel S., and Largaespada D.A. Micronucleus incidence and their chromosomal origin related to therapy in acute lymphoblastic leukaemia (ALL) patients: detection by micronucleus and FISH techniques. Terat. Carcinog. Mutagen. 21 5 (2001) 341-347
12. Elsendoorn T.J., Weijl N.I., Mithoe S., Zwindermann A.H., Van Dam F., De Zwart F.A., Tates A.D., and Osanto S. Chemoterapy-induced chromosomal damage in peripheral blood lymphocytes of cancer patients supplemented with antioxidants or placebo. Mutat. Res. 498 1-2 (2001) 145-158
13. Kopjar N., Garaj-Vrhovac V., and Milas I. Acute cytogenetic effects of antineoplastic drugs on peripheral blood lymphocytes in cancer patients chromosome aberrations and micronuclei. Tumori 88 4 (2002) 300-312
14. Torres-Bugarìn O., Ventura-Aguilar A., Zamora-Perez A., Gòmez-Meda B.C., Ramos-Ibarra M.L., Morgan-Villela G., Gutiérrez-Franco A., and Zùniga-Gonzàlez G. Evaluation of cisplatin + 5-FU, carboplatin + 5-FU, and ifosfamide + epirubicine regimens using the micronuclei test and nuclear abnormalities in the buccal mucosa. Mutat. Res. 565 (2004) 91-101
15. Ensslin A.S., Huber R., Pethran A., Römmelt H., Schierl R., Kulka U., and Fruhmann G. Biological monitoring of hospital pharmacy personnel occupationally exposed to cytostatic drugs: urinary excretion and cytogenetics studies. Int. Arch. Occup. Environ. Health 70 (1997) 205-208
16. Pilger A., Kohler I., Stettner H., Mader R.M., Rizovski B., Terkola R., Diem E., Franz-Hainzl E., Konnaris C., Valic E., and Rudiger H.W. Long-rem monitoring of sister chromatid exchanges and micronucleus frequencies in pharmacy personnel occupationally exposed to ytostatic drugs. Int. Arch. Occup. Environ. Health 73 (2000) 442-448
17. Maluf S.W., and Erdtmann B. Follow-up study of the genetic damage in lymphocytes of pharmacists and nurses handling antineoplastic drugs evaluated by cytokinesis-block micronuclei analysis and single cell gel electrophoresis assay. Mutat. Res. 471 (2000) 21-27
18. Hessel H., Radon K., Pethran A., Maisch B., Gröbmair S., Sautter I., and Fruhmann G. The genotoxic risk of hospital, pharmacy and medical personnel occupationally exposed to cytostatic drugs-evaluation by the micronucleus assay. Mutat. Res. 497 (2001) 101-109
19. Anwar W.A., Salama S.I., el Serafy M.M., Hemida S.A., and Hafez A.S. Chromosomal aberrations and micronucleus frequency in nurses occupationally exposed to cytotoxic drugs. Mutagenesis 9 4 (1994) 315-317
20. Fucic A., Jazbec A., Mijic A., Šešo-Šimic D., and Tomek R. Cytogenetic consequences after occupational exposure to antineoplastic drugs. Mutat. Res. 416 (1998) 59-66
21. Burgaz S., Karahali{dotless}l B., Bayrak P., Taşkin L., Yavuzaslan F., Bökesoy I., Bos R.P., and Platin Nurgün. Urinary cyclophosphamide excretion and micronuclei frequencies in peripheral lymphocytes and in exfoliated buccal epithelial cells of nurses handling antineoplastics. Mutat. Res. 439 (1999) 97-104
22. Machado-Santelli G.M., Cerqueira E.M., Oliveira C.T., and de Braganca Pereira C.A.A. Biomonitoring of nurses handling antineoplastic drugs. Mut. Res. 322 (1994) 203-208
23. Deng H., Zhang M., He J., Wu W., Jin L., Zheng W., Lou J., and Wang B. Investigating genetic damage in workers occupationally exposed to methotrexate using three genetic end-points. Mutagenesis 20 5 (2005) 351-357
24. Becker P., Scherthan H., and Zankl H. Use of centromere-specific DNA probe (p82H) in non-isotopic in situ hybridization for classification of micronuclei. Genes Chromosom. Cancer 2 (1990) 59-62
25. Migliore L., Bocciardi R., Macrì C., and Lojacono F. Cytogenetic damage induced in human lymphocytes by four vanadium compounds and micronucleus analysis by fluorescence in situ hybridization with a centromeric probe. Mutat. Res. 319 (1993) 206-213
26. Eastmond D.A., Schuler M., and Rupa D.S. Advantages and limitations of using fluorescence in situ hybridization for the detection of aneuploidy in interphase human cells. Mutat. Res. 348 4 (1995) 153-162
27. Migliore L., Cocchi L., and Scarpato R. Detection of the centromere in micronuclei by fluorescence in situ hybridization: its application to the human lymphocyte micronucleus assay after treatment with four suspected aneugens. Mutagenesis 11 (1996) 285-290
28. Migliore L., Cocchi L., Nesti C., and Sabbioni E. Micronuclei assay and FISH analysis in human lymphocytes treated with six metal salts. Environ. Mol. Mutagen. 34 (1999) 279-284
29. Laffon B., Pàsaro E., and Mèndez J. Genotoxic effects of styrene-7, 8-oxide in human white blood cells: comet assay in relation to the induction of sister-chromatid exchange and micronuclei. Mutat. Res. 491 (2001) 163-172
30. Kryscio A., Ulrich Muller W.U., Wojcik A., Kotschy N., Grobelny S., and Streffer C. A cytogenetic analysis of the long-term effect of uranium mining on peripheral lymphocytes using the micronucleus-centromere assay. Mutat. Res. 77 11 (2001) 1087-1093
31. Bolognesi C., Landini E., Perrone E., and Roggieri P. Cytogenetic biomonitoring of a floriculturist population in Italy: micronucleus analysis by fluorescence in situ hybridization (FISH) with an all-chromosome centromeric probe. Mutat. Res. 557 (2004) 109-117
32. Benova D., Hadjidekova V., Hristova R., Nikolova T., Boulanova M., Georgieva I., Grigorova M., Popov T., Panev T., Georgieva R., Natarajan A.T., Darroudi F., and Nilsson R. Cytogenetic effects of hexavalent chromium in Bulgarian chromium platers. Mutat. Res. 514 (2002) 29-38
33. Palus J., Rydzynski K., Dziubaltowska E., Wyszynska K., Natarajan A.T., and Nilsson R. Genotoxic effects of occupational exposure to lead and cadmium. Mutat. Res. 540 (2003) 19-28
34. Lewińska D., Ste{ogonek}pnik M., Krajewski W., Arkusz J., Stańczyk M., and Wrońska-Nofer T. Increased incidence of micronuclei assessed with the micronucleus assay and the fluorescence in situ hybridization (FISH) technique in peripheral blood lymphocytes of nurses exposed to nitrous oxide. Mutat. Res. 581 (2005) 1-9
35. Albertini R.J., Anderson D., Douglas G.R., Hagmar L., Hemminki K., Merlo F., Natarajan A.T., Norppa H., Shuker D.E.G., Tice R., Waters M.D., and Aitio A. IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans. Mutat. Res. 463 (2000) 111-172
36. Titenko-Holland N., Jacob R.A., Shang N., Balaraman A., and Smith M.T. Micronuclei in lymphocytes and exfoliated buccal cells of postmenopausal women with dietary changes in folate. Mutat. Res. 417 (1998) 101-114
37. Tolbert P.E., Shy C.M., and Allen J.W. Micronuclei and other nuclear anomalies in buccal smears: methods development. Mutat. Res. 271 (1992) 69-77
38. Cavallo D., Ursini C.L., Perniconi B., Di Francesco A., Giglio M., Rubino F.M., Marinaccio A., and Iavicoli S. Evaluation of genotoxic effects induced by exposure to antineoplastic drugs in lymphocytes and exfoliated buccal cells of oncology nurses and pharmacy employees. Mutat. Res. 587 (2005) 45-51
39. Voigt W., Kegel T., Weiss M., Mueller T., Simon H., and Schmoll H.J. Potential activity of paclitaxel, vinorelbine and gemcitabine in anaplastic thyroid carcinoma. J. Cancer Res. Clin. Oncol. 13 9 (2005) 585-590
40. Gonzalez-Cid M., Cuello M.T., and Larripa I. Comparison of the aneugenic effect of vinorelbine and vincristine in cultured human lymphocytes. Mutagenesis 14 1 (1999) 63-66